EUCTR2016-000789-53-AT
Active, not recruiting
Phase 1
A pilot trial to investigate the administration of von Willebrand factor concentrate (Willfact®, LFB France) in adult patients during extracorporeal membrane oxygenation - Willfact during ECMO
Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin0 sitesOctober 17, 2016
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Von Willebrand Disease (VWD)
- Sponsor
- Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin
- Status
- Active, not recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patients with the need of veno\-arterial or veno\-venous ECMO for a minimum of 48 hours
- •\- Age \= 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\- Patient with known thromboembolic event in the last 30 days
- •\- Inevitable lethal course
- •\- Severe Liver failure: Quick \< 30 %
- •\- Pregnancy
- •\- Patient with known refusal of a participation in this clinical trial
- •\- Active participation in another clinical trial
- •\- Any condition, including the presence of laboratory abnormalities, which would place the subject at unacceptable risk if he/she were to participate in the study or confound the ability to interpret data from the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE
Completed
Not Applicable
A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic DermatitisDiseases of the skin and subcutaneous tissueKCT0003177DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYA14
Not yet recruiting
Phase 2
Vel Tooth powder against dental biofilm and Gingival bleeding among ChildreCTRI/2023/09/058077ational Institute of Siddha
Active, not recruiting
Phase 1
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19)COVID-19 infection is being spread around the world with more than 400.000 cases. The spred of the disease is being a world health problem.Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001194-69-ESFélix Gutiérrez Rodero200
Recruiting
Not Applicable
Pilot study to evaluate the efficacy and safety of MegaNuovo in Pressure sore patients : single center, comparative, investigator-initiated pilot studyDiseases of the skin and subcutaneous tissueKCT0006745Yonsei University, Wonju Severance Christian Hospital30